The 2016 ASCP Annual Meeting will take place in Scottsdale, AZ from May 30 – June 3, 2016. The meeting will include representatives from academia, the National Institutes of Health (NIH), Food and Drug Administration (FDA), European regulatory agencies and industry to discuss key aspects of neuropsychiatric drug development, including the impact of diagnostic changes and personalized interventions based on biomarkers or genetic information.